Arts J, Herr I, Lansink M, Angel P, Kooistra T
Gaubius Laboratory, TNO-PG, PO Box 2215, 2301 CE Leiden, The Netherlands.
Nucleic Acids Res. 1997 Jan 15;25(2):311-7. doi: 10.1093/nar/25.2.311.
Tissue-type plasminogen activator (t-PA) gene expression in human endothelial cells and HeLa cells is stimulated by the protein kinase C activator phorbol 12-myristate 13-acetate (PMA) at the level of transcription. To study the mechanism of transcriptional regulation, we have characterized a segment of the t-PA gene extending from -135 to +100 by in vivo footprinting analysis [dimethyl sulphate (DMS) method] and gel mobility shift assay. In vivo footprinting analysis revealed changes in cleavage pattern in five distinct promoter elements in both endothelial cells and HeLa cells, including a PMA-responsive element (TRE), a CTF/NF-1 binding site and three GC-boxes, and an altered cleavage pattern of the TRE and CTF/NF-1 element after PMA treatment of HeLa cells. Although endothelial cells and HeLa cells differed in the exact G residues protected by nuclear proteins,in vitro bandshift analysis showed that nuclear protein binding to the t-PA promoter was qualitatively and quantitatively very similar in both cell types, except for the TRE. Protein binding to the TRE under non- stimulated conditions was much higher in human endothelial cells than in HeLa cells, and this TRE-bound protein showed a lower dissociation rate in the endothelial cells than in HeLa cells. In endothelial cells, the proteins bound to the TRE consisted mainly of the AP-1 family members JunD and Fra-2, while in HeLa cells predominantly JunD, FosB and Fra-2 were bound. The proteins bound to the other protected promoter elements were identified as SP-1 (GC-box II and III) and CTF/NF-1 (CTF/NF-1 binding site). After PMA treatment of the cells, AP-1 and SP-1 binding was increased two-fold in endothelial cell nuclear extracts and >20-fold in HeLa nuclear extracts. In the endothelial cells, all Jun and Fos forms (c-Jun, JunB, JunD, c-Fos, FosB, Fra-1 and Fra-2) were part of the AP-1 complex after PMA induction. In HeLa cells, the complex consisted predominantly of c-Jun and the Fos family members FosB and Fra-2. In the light of previous studies involving mutational analysis of the human and murine t-PA promoter our results underline an important role of the five identified promoter regions in basal and PMA-stimulated t-PA gene expression in intact human endothelial cells and HeLa cells. The small differences in DMS protection pattern and differences in the individual AP-1 components bound in endothelial cells and HeLa cells point to subtle cell-type specific differences in t-PA gene regulation.
蛋白激酶C激活剂佛波醇12-肉豆蔻酸酯13-乙酸酯(PMA)可在转录水平上刺激人内皮细胞和宫颈癌细胞(HeLa细胞)中组织型纤溶酶原激活剂(t-PA)基因的表达。为了研究转录调控机制,我们通过体内足迹分析[硫酸二甲酯(DMS)法]和凝胶迁移率变动分析对t-PA基因从-135至+100的片段进行了特征分析。体内足迹分析显示,在内皮细胞和HeLa细胞的五个不同启动子元件中,切割模式发生了变化,包括一个PMA反应元件(TRE)、一个CTF/NF-1结合位点和三个GC盒,并且在PMA处理HeLa细胞后,TRE和CTF/NF-1元件的切割模式发生了改变。尽管内皮细胞和HeLa细胞中受核蛋白保护的确切G残基有所不同,但体外条带迁移分析表明,除TRE外,两种细胞类型中与t-PA启动子结合的核蛋白在定性和定量上非常相似。在未刺激条件下,人内皮细胞中与TRE结合的蛋白比HeLa细胞中的高得多,并且这种与TRE结合的蛋白在内皮细胞中的解离速率比HeLa细胞中的低。在内皮细胞中,与TRE结合的蛋白主要由AP-1家族成员JunD和Fra-2组成,而在HeLa细胞中主要是JunD、FosB和Fra-2与之结合。与其他受保护的启动子元件结合的蛋白被鉴定为SP-1(GC盒II和III)和CTF/NF-1(CTF/NF-1结合位点)。细胞经PMA处理后,内皮细胞核提取物中AP-1和SP-1的结合增加了两倍,而HeLa细胞核提取物中增加了20倍以上。在内皮细胞中,PMA诱导后,所有Jun和Fos形式(c-Jun、JunB、JunD、c-Fos、FosB、Fra-1和Fra-2)都是AP-1复合物的一部分。在HeLa细胞中,该复合物主要由c-Jun以及Fos家族成员FosB和Fra-2组成。根据先前涉及人和鼠t-PA启动子突变分析的研究,我们的结果强调了所确定的五个启动子区域在完整人内皮细胞和HeLa细胞中基础和PMA刺激的t-PA基因表达中的重要作用。DMS保护模式的微小差异以及内皮细胞和HeLa细胞中结合的单个AP-1成分的差异表明t-PA基因调控存在细微的细胞类型特异性差异。